Early Rhythm Control Cuts Event Rate in Afib Patients

September 02, 2020

A study from ESC Congress 2020 details the effects of initiating rhythm control within the first year of an atrial fibrillation diagnosis.

Sean Pokorney, MD: IMPACT-AFib and the Struggle to Improve Anticoagulant Adherence

September 02, 2020

Lead investigator of IMPACT-AFib discusses the results of the study and how they inform clinicians on strategies to improve oral anticoagulant use.

Analysis of Outcomes, Trends with SAPIEN 3 Transcatheter Heart Valve

July 30, 2020

An analysis of the STS/ACC Transcatheter Valve Therapy Registry reviews trends associated with use of the SAPIEN 3 transcatheter heart valve.

Apixaban Tops Other DOACs, Warfarin for Stroke Events in AF Patients with CKD

July 11, 2020

A new analysis of Medicare data from 2011-2017 is shedding light on the comparative effectiveness of DOACs versus warfarin in patients with AF and chronic kidney disease.

Emergency Room Doctors Publish Guide on Cardiovascular Complications of COVID-19

May 18, 2020

Researchers from UVA Health have recently published a paper with the intent on educating emergency room physicians about the cardiac complications of COVID-19.

Novel Smartphone Trial Design Collects Large-Scale AF Data Very Rapidly

May 28, 2019

In this study, among participants with smartphone-detected AF, 72% had experienced no symptoms. This technology-based screening approach could have legs.

PRAGUE-12 at 5 Years: Stroke Rate Reduced, Sinus Rhythm Maintained

May 28, 2019

The 5-year PRAGUE-12 study outcomes show that LAA ablation in cardiac surgery patients with a history of atrial fibrillation reduces stroke rate vs cardiac surgery alone.

Test Your AFib IQ: 5 Questions

May 21, 2019

Test your knowledge of the 2019 "focused" updates to the 2014 AHA/ACC/HRS guidelines on the management of atrial fibrillation with this quick, 5-question quiz. 

ERADICATE-AF: Renal Artery Denervation Improves Results of Catheter Ablation in Atrial Fibrillation with Hypertension

May 14, 2019

SAN FRANCISCO--Study results reported at the 40th HRS Scientific Sessions showed at 1 year, more patients remained AF-free in the renal  denervation/catheter ablation group than in the group receiving catheter ablation alone (71.4% vs 57.8%). 

Transcutaneous Vagus Nerve Stimulation Significantly Reduces Atrial Fibrillation

May 14, 2019

SAN FRANCISCO― Results of the TREAT-AF trial showed burden of AF was reduced by 85% at 6 months using transcutaneous electrical stimulation of the vagus nerve, vs a sham procedure; findings were showcased at the 40th HRS Scientific Sessions.